The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD
Abstract
OBJECTIVE: To assess the efficacy and safety of clonidine hydrochloride extended-release tablets (CLON-XR) combined with stimulants (ie, methylphenidate or amphetamine) for attention-deficit/hyperactivity disorder (ADHD). PATIENTS AND METHODS: In this phase 3, double-blind, placebo-controlled trial, children and adolescents with hyperactive- or combined-subtype ADHD who had an inadequate response to their stable stimulant regimen were randomized to receive CLON-XR or placebo in combination with their baseline stimulant medication. Predefined efficacy measures evaluated change from baseline to week 5. Safety was assessed by spontaneously reported adverse events, vital signs, electrocardiogram recordings, and clinical laboratory values. Improvement from baseline for all efficacy measures was evaluated using analysis of covariance. RESULTS: Of 198 patients randomized, 102 received CLON-XR plus stimulant and 96 received placebo plus stimulant. At week 5, greater improvement from baseline in ADHD Rating Scale IV (ADHD-RS-IV) total score (95% confidence interval: −7.83 to −1.13; P = .009), ADHD-RS-IV hyperactivity and inattention subscale scores (P = .014 and P = .017, respectively), Conners' Parent Rating Scale scores (P < .062), Clinical Global Impression of Severity (P = .021), Clinical Global Impression of Improvement (P = .006), and Parent Global Assessment (P = .001) was observed in the CLON-XR plus stimulant group versus the placebo plus stimulant group. Adverse events and changes in vital signs in the CLON-XR group were generally mild. CONCLUSIONS: The results of this study suggest that CLON-XR in combination with stimulants is useful in reducing ADHD in children and adolescents with partial response to stimulants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A transdermal patch of clonidine is available, as is a sustained release oral formulation that was recently approved for the treatment of ADHD, 124 but has not been studied for use in children and adolescents with CTD.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Treatment of ADHD in children with tics: A randomized controlled trial
The Tourette’s Syndrome Study Group (2002) · Neurology · doi:10.1212/wnl.58.4.527 · Cited by 504
Jain, R., Segal, S., Kollins, S. H., & Khayrallah, M. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.11.005 · Cited by 142
Self-citationRommelse, N. N. J., Altink, M. E., Fliers, E. A., Martin, N. C., Buschgens, C. J. M., Hartman, C. A., Buitelaar, J. K., Faraone, S. V., Sergeant, J. A., & Oosterlaan, J. (2009) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-009-9312-6 · Cited by 138
Evolution of the treatment of attention-deficit/hyperactivity disorder in children: A review
Findling, R. L. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.05.006 · Cited by 129
Self-citation
Research works printed but not linked: 15
- American Psychiatric Association, 2000, Diagnostic and Statistical Manual of Mental Disorders
- Froehlich, 2007, Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children, Arch Pediatr Adolesc Med, 161, 857, 10.1001/archpedi.161.9.857 · DOI · Paper page
- Jensen, 1993, Anxiety and depressive disorders in attention deficit disorder with hyperactivity: new findings, Am J Psychiatry, 150, 1203, 10.1176/ajp.150.8.1203 · DOI · Paper page
- Newcorn, 2001, Symptom profiles in children with ADHD: effects of comorbidity and gender, J Am Acad Child Adolesc Psychiatry, 40, 137, 10.1097/00004583-200102000-00008 · DOI · Paper page
- Barbaresi, 2006, Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study, J Dev Behav Pediatr, 27, 1, 10.1097/00004703-200602000-00001 · DOI
- Connor, 2000, A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder, Clin Pediatr (Phila), 39, 15, 10.1177/000992280003900102 · DOI · Paper page
- Hunt, 1985, Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial, J Am Acad Child Psychiatry, 24, 617, 10.1016/S0002-7138(09)60065-0 · DOI · Paper page
- Agarwal, 2001, Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation, Ment Retard, 39, 259, 10.1352/0047-6765(2001)039<0259:DBPCTO>2.0.CO;2 · DOI
- Hazell, 2003, A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children, J Am Acad Child Adolesc Psychiatry, 42, 886, 10.1097/01.CHI.0000046908.27264.00 · DOI · Paper page
- Nair, 2009, Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD, J Trop Pediatr, 55, 116, 10.1093/tropej/fmn117 · DOI
- Palumbo, 2008, Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes, J Am Acad Child Adolesc Psychiatry, 47, 180, 10.1097/chi.0b013e31815d9af7 · DOI
- Schvehla, 1994, Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit, South Med J, 87, 692, 10.1097/00007611-199407000-00004 · DOI
- Efron, 2003, Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists, Pediatrics, 111, 372, 10.1542/peds.111.2.372 · DOI
- Hazell, 1996, Management of children prescribed psychostimulant medication for attention deficit hyperactivity disorder in the Hunter region of NSW, Med J Aust, 165, 477, 10.5694/j.1326-5377.1996.tb138611.x · DOI
- DuPaul, 1998, ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation
Cited by
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., et al. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.11.001 · Cited by 686
Catalá-López, F., Hutton, B., Núñez-Beltrán, A., Page, M. J., Ridao, M., Macías Saint-Gerons, D., Catalá, M. A., Tabarés-Seisdedos, R., & Moher, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0180355 · Cited by 396
Evidence-based pharmacological treatment options for ADHD in children and adolescents
Mechler, K., Banaschewski, T., Hohmann, S., & Häge, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107940 · Cited by 293
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.015 · Cited by 276
Clonidine Extended-Release: In Attention-Deficit Hyperactivity Disorder
Croxtall, J. D. (2011) · Pediatric Drugs · doi:10.2165/11208100-000000000-00000 · Cited by 190
Metadata
- Authors
- Kollins, S. H., Jain, R., Brams, M., Segal, S., Findling, R. L., Wigal, S. B., & Khayrallah, M.
- Affiliations
- Department of Psychiatry, Duke University Medical Center, Durham, North Carolina;
- Psychiatric Drug Research, R/D Clinical Research Inc, Lake Jackson, Texas;
- Bayou City Research Ltd, Houston, Texas;
- Segal Institute for Clinical Research, North Miami, Florida;
- Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio;
- Department of Pediatrics, University of California–Irvine, Irvine, California; and
- Addrenex Pharmaceuticals Inc, a Shionogi Company, Durham, North Carolina
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2011-06-01
- Volume
- 127
- Issue
- 6
- Pages
- e1406-e1413
- ISSN
- 0031-4005
- 1098-4275
- Cited by
- 125
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD. https://app.cochat.ai/papers/10.1542/peds.2010-1260
- The paper
- Kollins, S. H., Jain, R., Brams, M., Segal, S., Findling, R. L., Wigal, S. B., & Khayrallah, M. (2011). Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD. Pediatrics. https://doi.org/10.1542/peds.2010-1260
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.